Literature DB >> 7553876

Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein.

G C Telling1, M Scott, J Mastrianni, R Gabizon, M Torchia, F E Cohen, S J DeArmond, S B Prusiner.   

Abstract

Transgenic (Tg) mice expressing human (Hu) and chimeric prion protein (PrP) genes were inoculated with brain extracts from humans with inherited or sporadic prion disease to investigate the mechanism by which PrPC is transformed into PrPSc. Although Tg(HuPrP) mice expressed high levels of HuPrPC, they were resistant to human prions. They became susceptible to human prions upon ablation of the mouse (Mo) PrP gene. In contrast, mice expressing low levels of the chimeric transgene were susceptible to human prions and registered only a modest decrease in incubation times upon MoPrP gene disruption. These and other findings argue that a species-specific macromolecule, provisionally designated protein X, participates in prion formation. While the results demonstrate that PrPSc binds to PrPC in a region delimited by codons 96 to 167, they also suggest that PrPC binds protein X through residues near the C-terminus. Protein X might function as a molecular chaperone in the formation of PrPSc.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7553876     DOI: 10.1016/0092-8674(95)90236-8

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  221 in total

1.  Sulfated glycans and elevated temperature stimulate PrP(Sc)-dependent cell-free formation of protease-resistant prion protein.

Authors:  C Wong; L W Xiong; M Horiuchi; L Raymond; K Wehrly; B Chesebro; B Caughey
Journal:  EMBO J       Date:  2001-02-01       Impact factor: 11.598

2.  Dominant-negative inhibition of prion formation diminished by deletion mutagenesis of the prion protein.

Authors:  L Zulianello; K Kaneko; M Scott; S Erpel; D Han; F E Cohen; S B Prusiner
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

3.  Mimicking dominant negative inhibition of prion replication through structure-based drug design.

Authors:  V Perrier; A C Wallace; K Kaneko; J Safar; S B Prusiner; F E Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

4.  The role of dimerization in prion replication.

Authors:  Peter Tompa; Gábor E Tusnády; Peter Friedrich; István Simon
Journal:  Biophys J       Date:  2002-04       Impact factor: 4.033

5.  Computational studies on prion proteins: effect of Ala(117)-->Val mutation.

Authors:  Noriaki Okimoto; Kazunori Yamanaka; Atsushi Suenaga; Masayuki Hata; Tyuji Hoshino
Journal:  Biophys J       Date:  2002-05       Impact factor: 4.033

6.  Strain-specified relative conformational stability of the scrapie prion protein.

Authors:  D Peretz; M R Scott; D Groth; R A Williamson; D R Burton; F E Cohen; S B Prusiner
Journal:  Protein Sci       Date:  2001-04       Impact factor: 6.725

7.  Stress-inducible protein 1 is a cell surface ligand for cellular prion that triggers neuroprotection.

Authors:  Silvio M Zanata; Marilene H Lopes; Adriana F Mercadante; Glaucia N M Hajj; Luciana B Chiarini; Regina Nomizo; Adriana R O Freitas; Ana L B Cabral; Kil S Lee; Maria A Juliano; Elizabeth de Oliveira; Saul G Jachieri; Alma Burlingame; Lan Huang; Rafael Linden; Ricardo R Brentani; Vilma R Martins
Journal:  EMBO J       Date:  2002-07-01       Impact factor: 11.598

8.  One O-linked sugar can affect the coil-to-beta structural transition of the prion peptide.

Authors:  Pei-Yeh Chen; Chun-Cheng Lin; Yin-Ting Chang; Su-Ching Lin; Sunney I Chan
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-16       Impact factor: 11.205

Review 9.  Insights into Mechanisms of Transmission and Pathogenesis from Transgenic Mouse Models of Prion Diseases.

Authors:  Julie A Moreno; Glenn C Telling
Journal:  Methods Mol Biol       Date:  2017

10.  Diagnosis of human prion disease.

Authors:  Jiri G Safar; Michael D Geschwind; Camille Deering; Svetlana Didorenko; Mamta Sattavat; Henry Sanchez; Ana Serban; Martin Vey; Henry Baron; Kurt Giles; Bruce L Miller; Stephen J Dearmond; Stanley B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.